TY - JOUR
T1 - Risedronate in the treatment of Murine Chagas' disease
AU - Bouzahzah, Boumediene
AU - Jelicks, Linda A.
AU - Morris, Stephen A.
AU - Weiss, Louis M.
AU - Tanowitz, Herbert B.
N1 - Funding Information:
Acknowledgements Supported in part by grants from Proctor & Gamble and from the National Institutes of Health AI-062730 (LAJ), AI-12770, AI-052739 and HL-073732 (HBT). We wish to thank Dazhi Zhao and Vitalyi Shtutin for their technical assistance.
PY - 2005/6
Y1 - 2005/6
N2 - Risedronate, a bisphosphonate, was used to treat CD-1 mice infected with the Brazil strain of Trypanosoma cruzi. When given by subcutaneous injection 3 times/week, there was a significant reduction in mortality, however, the myocardial pathology and right ventricular dilation was unchanged in these mice compared to control animals. In C57BL/6 mice infected with the Tulahuen strain, there was no change in mortality in response to risedronate treatment. These data suggest that this class of compounds has activity against T. cruzi in vivo and illustrate the utility of imaging and pathologic studies as adjuncts in the evaluation of therapeutic compounds as treatments for experimental Chagas' disease. In addition, it underscores the need to use different strains of T. cruzi.
AB - Risedronate, a bisphosphonate, was used to treat CD-1 mice infected with the Brazil strain of Trypanosoma cruzi. When given by subcutaneous injection 3 times/week, there was a significant reduction in mortality, however, the myocardial pathology and right ventricular dilation was unchanged in these mice compared to control animals. In C57BL/6 mice infected with the Tulahuen strain, there was no change in mortality in response to risedronate treatment. These data suggest that this class of compounds has activity against T. cruzi in vivo and illustrate the utility of imaging and pathologic studies as adjuncts in the evaluation of therapeutic compounds as treatments for experimental Chagas' disease. In addition, it underscores the need to use different strains of T. cruzi.
UR - http://www.scopus.com/inward/record.url?scp=20944439686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20944439686&partnerID=8YFLogxK
U2 - 10.1007/s00436-005-1331-9
DO - 10.1007/s00436-005-1331-9
M3 - Article
C2 - 15844009
AN - SCOPUS:20944439686
SN - 0932-0113
VL - 96
SP - 184
EP - 187
JO - Parasitology research
JF - Parasitology research
IS - 3
ER -
